Treatment patterns, health resource utilization and costs among central precocious puberty patients treated with leuprolide or histrelin: An examination of the commercial and Medicaid populations.

Conclusions: Mean overall healthcare costs were similar between CPP patients treated with leuprolide and those treated with histrelin. Medicaid patients generally received less testing and were less likely to receive specialist care. Patients treated with histrelin had fewer office visits but also had a shorter overall treatment. PMID: 31766907 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research